-
FEATURED CONTENT
FDA on Wednesday announced that chief scientist Namandjé Bumpus will be replacing Janet Woodcock, who is retiring, as principal deputy commissioner next year, in today's bite-sized hospital and health industry news from Maryland, Nevada, and Texas.
- Maryland: FDA on Wednesday announced that chief scientist Namandjé Bumpus will be replacing Janet Woodcock, who is retiring, as principal deputy commissioner next year. Bumpus was named chief scientist at FDA in June 2022 and works closely with FDA's product centers. Bumpus also played a large role in the expansion of FDA's regulation of cosmetics. Previously, Bumpus served as professor and department chair at Johns Hopkins University School of Medicine's department of pharmacology and molecular science. (Wilkerson, STAT+ [subscription required], 11/29)
- Nevada: Judge James T. Russell last week rejected a ballot measure that would have constitutionally protected abortion rights in Nevada, arguing the measure was too broad as it included "all matters relating to pregnancy," rather than just abortion. Russell said the measure's wording didn't fit with Nevada's single-subject rule stating a referendum or initiative "must embrace one subject." Nevadans for Reproductive Freedom, who proposed the ballot measure, said they plan to appeal the decision. (Balevic, Business Insider, 11/25)
- Texas: UT Health East Texas last week experienced a network outage caused by a ransomware attack that impacted the health system's parent company, Ardent Health Services. According to a statement from Ardent, the incident led Ardent's technology team to proactively take its network offline, suspending all user access to its information technology applications. In response, the ED at UT Health East Texas was placed on divert status as a precaution. Ardent said it can't confirm the extent to which any patient health or financial data has been compromised. (Wellerman, CBS19, 11/27)
Don't miss out on the latest Advisory Board insights
Create your free account to access 1 resource, including the latest research and webinars.
Want access without creating an account?
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Become a member to access all of Advisory Board's resources, events, and experts
Never miss out on the latest innovative health care content tailored to you.
Benefits include:
You've reached your limit of free insights
